Ensysce Biosciences Files 2024 10-K
Ticker: ENSCW · Form: 10-K · Filed: Mar 10, 2025 · CIK: 1716947
| Field | Detail |
|---|---|
| Company | Ensysce Biosciences, INC. (ENSCW) |
| Form Type | 10-K |
| Filed Date | Mar 10, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Ensysce Biosciences filed its 2024 10-K. Financials for 2023-2024 detailed.
AI Summary
Ensysce Biosciences, Inc. filed its 2024 10-K on March 10, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly Leisure Acquisition Corp., is focused on pharmaceutical preparations. Key financial data for the fiscal years 2023 and 2024, including common stock, additional paid-in capital, retained earnings, and noncontrolling interest, are detailed in the filing.
Why It Matters
This filing provides investors with a comprehensive overview of Ensysce Biosciences' financial health and operational status for the fiscal year 2024, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Ensysce Biosciences faces inherent risks related to drug development, regulatory approvals, and market competition, which are typical for the industry.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2023-12-31 — Prior Fiscal Year End (Comparison point for financial data)
Key Players & Entities
- Ensysce Biosciences, Inc. (company) — Filer of the 10-K
- Leisure Acquisition Corp. (company) — Former name of Ensysce Biosciences, Inc.
- 2024-12-31 (date) — Fiscal year end
- 2025-03-10 (date) — Filing date
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the primary business of Ensysce Biosciences, Inc.?
Ensysce Biosciences, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code 2834.
When was the 10-K filing submitted?
The 10-K filing was submitted on March 10, 2025.
What was Ensysce Biosciences, Inc.'s former name?
Ensysce Biosciences, Inc. was formerly known as Leisure Acquisition Corp.
What is the fiscal year end for the reported period?
The fiscal year end for the reported period is December 31, 2024.
What financial components are detailed for the fiscal years 2023 and 2024?
The filing details components such as Common Stock, Additional Paid-In Capital, Retained Earnings, and Noncontrolling Interest for the fiscal years 2023 and 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 10, 2025 regarding Ensysce Biosciences, Inc. (ENSCW).